|1.||Gridelli, Cesare: 15 articles (07/2014 - 04/2002)|
|2.||Gebbia, Vittorio: 14 articles (08/2010 - 01/2002)|
|3.||Georgoulias, V: 13 articles (04/2015 - 01/2001)|
|4.||Goldhirsch, A: 13 articles (09/2009 - 01/2000)|
|5.||Shepherd, Frances A: 12 articles (05/2014 - 08/2003)|
|6.||Seymour, Lesley: 12 articles (10/2013 - 08/2003)|
|7.||Lorusso, V: 11 articles (11/2014 - 01/2000)|
|8.||Perrone, Francesco: 10 articles (10/2013 - 06/2002)|
|9.||Georgoulias, Vassilis: 10 articles (02/2013 - 11/2004)|
|10.||Kubota, Kaoru: 9 articles (08/2013 - 04/2004)|
|1.||Breast Neoplasms (Breast Cancer)
04/01/2012 - "Taken together, these data indicate that oral vinorelbine is a highly effective and well tolerated agent which can be used in first-line and subsequent metastatic breast cancer settings. "
01/01/1999 - "Vinorelbine (VNR) is highly active in metastatic breast cancer (MBC) and has shown an overall response rate of 40%-50% as first-line treatment. "
05/01/1998 - "Vinorelbine (VNR) is highly active in metastatic breast cancer (MBC) and has shown an overall response rate of 40%-50% as first-line treatment. "
04/01/2006 - "In addition,we explain why it took 17 years for vinorelbine to be approved despite the fact that as early as the beginning of development, it was scientifically proven to be very useful in patients with breast cancer, and that the new drug application was submitted in 1993. "
01/01/2001 - "Vinorelbine has proven to be effective in pretreated metastatic breast cancer patients. "
|2.||Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
07/01/2000 - "There is a high level of evidence that vinorelbine is an effective agent for the treatment of non-small-cell lung cancer."
04/01/1999 - "Vinorelbine is a semisynthetic vinca alkaloid that is effective against advanced non-small cell lung cancer (NSCLC). "
10/01/1999 - "Combinations of vinorelbine with other nonplatinum agents show promising results in phase I and phase II trials in non-small cell lung cancer (NSCLC). "
01/01/2015 - "Metronomic oral vinorelbine could be a safe option for elderly patients with advanced non small cell lung cancer (NSCLC). "
01/01/2015 - "Metronomic oral vinorelbine as first-line treatment in elderly patients with advanced non-small cell lung cancer: results of a phase II trial (MOVE trial)."
05/01/2010 - "Compared with free vinorelbine (Free Vino), M-Vino was more effective in inhibiting the growth of tumor cells in vitro, inducing G(2)/M phase arrest and apoptosis of tumor cells. "
06/01/2015 - "Vinorelbine appeared to be effective in the treatment of several tumor types in dogs. "
11/01/2000 - "In both patients, vinorelbine treatment improved several clinical indicators of cancer symptomatology including serum LDH, levels of other clinical blood tests, as well as a subjective assessment of the quality of life (QOL). "
10/01/2015 - "This phase I trial assessed afatinib, an irreversible ErbB family blocker, plus vinorelbine in Japanese patients with advanced solid tumors not amenable to standard treatment. "
01/01/2013 - "Dose selection trial of metronomic oral vinorelbine monotherapy in patients with metastatic cancer: a hellenic cooperative oncology group clinical translational study."
|4.||Lung Neoplasms (Lung Cancer)
03/01/2012 - "In RM-1/BDF1 and Lewis lung cancer/c57 models, antitumor efficacy was also considerably improved after vinorelbine encapsulation into 5ssa vesicles. "
11/01/2000 - "[Improvement in quality of life with vinorelbine as a single agent in two patients with recurrent lung cancer]."
01/01/2013 - "In this study, we explored effects of vinorelbine in multi-drug resistance reversal of human lung cancer A549/DDP cells. "
02/01/2005 - "These studies for the first time show that RLIP76 mediates vinorelbine transport and is capable of conferring drug accumulation defect and resistance to lung cancer cells."
11/01/2003 - "The landmark Elderly Lung Cancer Vinorelbine Italian Study Group trial and the Multicentre Italian Lung Cancer in the Elderly Study clarified the role of vinorelbine in the treatment of elderly patients. "
12/01/2009 - "Therapeutic efficacy evaluation of 111In-labeled PEGylated liposomal vinorelbine in murine colon carcinoma with multimodalities of molecular imaging."
06/01/2007 - "Oral versus intravenous administration of vinorelbine as a single agent for the first-line treatment of metastatic nonsmall cell lung carcinoma (NSCLC): A randomized phase II trial."
10/01/1999 - "The purpose of this study was to determine the efficacy of vinorelbine given by 96-hour continuous infusion to patients with refractory metastatic breast carcinoma patients. "
12/01/2015 - "The goal of this study was to evaluate the anti-tumour activity and toxicoses of vinorelbine as a palliative rescue therapy for dogs with primary urinary bladder carcinoma. "
08/01/2005 - "A clinical phase II study of cisplatinum and vinorelbine (PVn) in advanced breast carcinoma (ABC)."
|1.||Drug Therapy (Chemotherapy)
|2.||Combination Drug Therapy (Combination Chemotherapy)
|5.||Heterologous Transplantation (Xenotransplantation)